Trial: 202110084

A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection with Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients NYMC 581

Phase

II

Principal Investigator

Shenoy, Shalini

Disease Site

Leukemia, other; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov